Earth Science Tech, Inc. Attends the Biggest Cannabis Expo in Canada, Sponsors and Attends 3 U.S. Cannabis Expos

DORAL, Florida, June 05, 2018 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC: ETST) (“ETST" or the “Company"), an innovative biotech company focused on the cannabidiol (CBD), nutraceutical and pharmaceutical fields, medical devices, as well as research and development, offers a report on the company’s presence at four recent cannabis expos held in Canada and the United States. Over the past three weeks, Earth Science Tech attended the Toronto Lift & Co. Expo, sponsored and attended the CannXperience and Florida Medical Cannabis Conference & Exhibition, and sponsored the Cannabis World Congress & Business Expo.  

Industry Day and Expo at the Lift and Co. Expo
The two Lift and Co. Expos  in Toronto and Vancouver  are the premier events for anyone involved in the Canadian cannabis industry, making it a perfect place for the ETST team to appear. Dr. Michel Aubé , the Company’s CEO & CSO, attended the event, networking with key individuals.

 “I met many leaders in the Canadian medical cannabis industry, as well as future leaders in the burgeoning legal recreational cannabis industry and  visionary lenders who are active in financing cannabis industry growth,” Aubé said. “We will pursue some of these new relationships in the coming months.”

CannXperience and Florida Medical Cannabis Conference & Exhibition
Both CannXperience and Florida Medical Cannabis Conference - held in Fort Lauderdale  and Sarasota - involved Florida’s medical cannabis industry. ETST’ss COO Gagan Hunter attended both events, handing out samples and marketing material at a company-sponsored booth while representing the brand in his 15-minute speech presentation. The Company also helped sponsor the event, providing the ETST logo and Company information with event marketing material distributed throughout the event.

 “Both events were very effective in spreading brand awareness, learning more about the industry, and networking,” Hunter said. “I got a lot of positive feedback on our brand and connected with many doctors, potential investors, and potential synergistic companies.”

Cannabis World Congress & Business Expo
The Cannabis World Congress & Business Expo  in New York is a national level cannabis event which the Company sponsored to spread brand awareness.. The Company’s President and Director, Nickolas S. Tabraue, attended the event, learning from other companies and networking with individuals.

 “Thanks to our passionate and like-minded team, we are now able to participate in beneficial cannabis industry events to spread awareness and network,” Tabraue said.. “A lot was achieved by sponsoring and attending the four events during the past three weeks, leaving a strong footprint in the cannabis industry. We look forward on attending more events to come and sharing many exciting updates very soon.”

About Earth Science Tech, Inc. (ETST)
Earth Science Tech, Inc. (“ETST”) offers the highest purity and quality high-grade full spectrum cannabinoid oil on the market. There are positive results in studies on breast cancer and immune cells through the University of Central Oklahoma, and studies through DV Biologics prove it lowers cortisol and functions as a neuro-protectant, with positive result case studies through key health organizations. ETST formulates, markets, and distributes the CBD oil used for its studies to the public, offering the most effective quality of CBD on the market.
To learn more, please visit: 

ETST currently has three wholly owned subsidiaries focused on developing its role as a world leader in the CBD space and expanding its work in the pharmaceutical and medical device sectors. These subsidiaries include:

Earth Science Pharmaceutical
Earth Science Pharmaceutical, Inc. is a wholly owned subsidiary of Earth Science Tech, Inc (ETST). Earth Science Pharma, Inc. ("ESP") is committed to the development of low cost, noninvasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections and/or diseases. ESP's CEO and chief science officer Michel Aubé is leading the company’s research and development efforts. The company’s first medical device, MSN-2, is a home kit designed for the detection of STIs, such as chlamydia, from a self-obtained gynecological specimen. ESP is working to develop and bring to market medical devices and vaccines that meet the specific needs of women.
To learn more please visit: 

Cannabis Therapeutics
Cannabis Therapeutics, Inc. is a wholly owned subsidiary of Earth Science Tech, Inc. (ETST). Cannabis Therapeutics, Inc. (“CTI”), which is poised to take a leadership role in the development of new, leading-edge, cannabinoid-based pharmaceutical and nutraceutical products. CTI is invested in research and development to explore and harness the medicinal power of cannabidiol. The company holds three provisional application patents for a CBD product that is focused on developing treatments for breast and ovarian cancers, as well as two generic CBD based pharmaceutical drugs.
To learn more please visit:  

KannaBidioid, Inc. is a wholly owned subsidiary of Earth Science Tech, Inc. (ETST). KannaBidioiD, Inc. (“KBD”) provides a wide variety of products geared toward the recreational space of cannabis. KBD’s unique Kanna and CBD formulation is sold and distributed in CBD-infused vapes/e-liquids products. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhanced focus and the added benefit of assisting with nicotine reduction therapy.
To learn more please visit: 

Earth Science Foundation, Inc.
Earth Science Foundation, Inc., is awholly owned subsidiary of Earth Science Tech, Inc. (ETST). Earth Science Foundation, Inc. ("ESF") is in the process of becoming a non-profit organization to accept grants and donations to conduct further studies and help donate Earth Science Tech, Inc.'s effective CBD products to those in need.
To learn more please visit:

SAFE HARBOR ACT: Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including words such as "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will," and other similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events or otherwise.


Contact Data